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The human intestinal epithelium consists of a single layer of epithelial cells that forms
a barrier against food antigens and the resident microbiota within the lumen. This deli-
cately balanced organ functions in a highly sophisticated manner to uphold the fidelity
of the intestinal epithelium and to eliminate pathogenic microorganisms. On the luminal
side, this barrier is fortified by a thick mucus layer, and on the serosal side exists the
lamina propria containing a resident population of immune cells. Pathogens that are able
to breach this barrier disrupt the healthy epithelial lining by interfering with the regula-
tory mechanisms that govern the normal balance of intestinal architecture and function.
This disruption results in a coordinated innate immune response deployed to eliminate the
intruder that includes the release of antimicrobial peptides, activation of pattern-recognition
receptors, and recruitment of a variety of immune cells. In the case of Salmonella enterica
serovar typhimurium (S. typhimurium) infection, induction of an inflammatory response
has been linked to its virulence mechanism, the type III secretion system (T3SS).TheT3SS
secretes protein effectors that exploit the host’s cell biology to facilitate bacterial entry
and intracellular survival, and to modulate the host immune response. As the role of the
intestinal epithelium in initiating an immune response has been increasingly realized, this
review will highlight recent research that details progress made in understanding mech-
anisms underlying the mucosal inflammatory response to Salmonella infection, and how
such inflammatory responses impact pathogenic fitness of this organism.
Keywords: Salmonella typhimurium, mucins, microbiota, epithelial barrier, immune recognition, neutrophil
recruitment, mucosal inflammation, PMN transmigration
INTRODUCTION
Salmonella enterica serovar typhimurium (S. typhimurium) is
a Gram-negative, facultative, intracellular anaerobe that causes
severe inflammation of the intestinal mucosal epithelium result-
ing in gastroenteritis. S. typhimurium causes disease through
its primary virulence mechanism, the type III secretion system
(T3SS). There are two T3SSs that are encoded by two regions
of the bacterial chromosome called Salmonella pathogenicity
island 1 and Salmonella pathogenicity island 2 (SPI-1 and SPI-2).
These pathogenicity islands also encode effector proteins that are
secreted from the T3SS and translocated into epithelial cells at the
mucosal surface of the intestine. Upon contact with the mucosal
epithelium, SPI-1 encoded effector proteins are translocated into
epithelial cells and promote bacterial entry and inflammation.
SPI-2 encoded effector proteins generally function to maintain
the intracellular survival of S. typhimurium after the organism
has been macropinocytosed by epithelial cells. More recent stud-
ies, however, suggest that SPI-1 and SPI-2 effector proteins may
not be as functionally compartmentalized as originally thought
(1–3).
The architecture of the mucosal epithelium contains several
barriers that attempt to prevent or impede infection by patho-
genic bacteria. Mechanisms of protection are employed by all of
these barriers in order to maintain the integrity of the epithelial cell
monolayer and limit inflammation-associated damage (Figure 1).
S. typhimurium can modulate the signaling pathways that govern
these mechanisms, including targeting specific proteins or induc-
ing pathways through functional mimicry, in order to provide
itself with an ecological advantage with its T3SS virulence mech-
anism. Although S. typhimurium can, in certain instances, bypass
the innate immune response, the adaptive inflammatory immune
response is in most instances capable of clearing the pathogen,
albeit with increased damage to the mucosal epithelium.
ARCHITECTURE OF THE MUCOSAL EPITHELIUM: BARRIERS
AGAINST INFECTION
MUCUS/MUCINS
The luminal side of the intestinal epithelium is covered with a thick
layer of mucus primarily composed of mucins, the main secre-
tory product of goblet cells (Figure 1). Mucins are high molecular
weight glycoproteins that aggregate to form a “gel-like” barrier
to defend against endogenous or exogenous luminal insults. To
date, at least 17 highly conserved mucins have been identified,
each with varying specificities for different epithelial tissues [for
review, see Ref. (4)]. Furthermore, these mucins have been cate-
gorized into two major groups: cell surface mucins and secreted
mucins (Figure 1). Of these two categories, it is the secreted mucins
that form the major structural component of the mucosal layer,
and out of the known secreted mucin proteins, MUC2, MUC5AC,
MUC5B, MUC6, and MUC19 are classified as gel-forming for
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FIGURE 1 | Architecture of the mucosal surface. The mucosal surface of the
intestine contains a single layer of epithelial cells. The monolayer of epithelial
cells is fortified by a layer of mucus (yellow) produced by Goblet cells (blue
cells with yellow granules). This thick mucus layer contains membrane bound
and secreted mucins. The antimicrobial peptides (red) secreted by Paneth
cells (blue cells with red granules) reside in the thick mucus layer, providing
another form of protection against both pathogenic and commensal bacteria.
Antimicrobial peptides include defensins, cathelicidins, and histatins. Plasma
B cells (light green) reside in the subepithelial region and produce secretory
IgA (blue and red antibody ). Secreted IgA is found in the subepithelial region
and the lumen. Resident microbiota (green) reside in the outer mucus layer,
providing yet another barrier to pathogenic infection. The majority of resident
microbiota belong to two phyla – Firmicutes and Cytophaga–Flavobacterium–
Bacteroidetes. The seal between epithelial cells is maintained by tight
junctions (orange bars). Tight junctions are dynamic structures composed of
zonula occludens and junctional adhesion molecules.
human mucosal surfaces [for review, see Ref. (5, 6)]. The pre-
dominant mucin comprising the mucus layer of the intestinal
epithelium is MUC2, although MUC5AC has been shown to be
expressed in the mucus layer of the fetal intestine (7).
The mucosal layer consists of an inner layer of mucus that
is firmly adherent to the intestinal epithelial cells (mainly com-
prised of cell surface mucins) and a looser outer layer of mucus
(mainly comprised of secreted mucins) [for review, see Ref. (8)].
For quite some time, the mucus layer of epithelial surfaces was
thought to solely serve the purpose of providing a physical barrier,
preventing access of pathogenic bacteria or resident microbiota
to the epithelial cells. However, it has been increasingly realized
that the mucins in the outer sublayer of the mucosal barrier also
provide an energy source for both resident microbiota and patho-
genic microorganisms capable of adhering to the mucus layer. This
layer provides both commensal and pathogenic microorganisms
with a niche in which to grow and colonize the intestine [Ref. (9);
for review, see Ref. (10)]. The inner layer of the mucosal surface
is considered “sterile,” largely due to the presence of antimicro-
bial peptides secreted by Paneth cells (Figure 1, discussed later),
thereby limiting bacterial colonization to the outer mucus layer
[Ref. (8); for review, see Ref. (11, 12)].
Certain cell surface mucins in the inner mucus layer also
directly play a role in protecting against bacterial colonization on
the epithelial surface by acting as pathogen-binding decoys. For
example, epithelial cells can release Muc1 (called mucin shedding)
in response to Helicobacter pylori infection, and Muc1 will bind
the bacteria, preventing its adhesion to the intestinal epithelium
(8). Furthermore, it has been shown that approximately fivefold
more H. pylori colonize the intestinal epithelium of Muc1−/−mice
than wild-type mice (13). Although the thick mucus layer pro-
vides protection in the form of a physical barrier, it is significant
to note that the necessity to maintain healthy intestinal microflora
does provide pathogenic bacteria with the same energy source
and corresponding growth advantage as well. This advantage
has allowed certain pathogenic bacteria to develop mechanisms
to circumvent the protection provided by the mucus sublayers
and infect the underlying epithelial cells. As an example, certain
pathogenic Escherichia coli (E. coli) secrete mucinolytic proteins,
thus allowing them to persist and colonize within the mucus
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layer (14, 15). Unlike E. coli, S. typhimurium does not enzymati-
cally degrade mucus in order to colonize the mucosal epithelium.
Rather, mucins have actually been shown to be the binding sites
for S. typhimurium, and in particular a 250-kDa neutral mucin has
been implicated as a receptor for S. typhimurium (9).
RESIDENT MICROBIOTA
The mammalian intestinal microflora contains ~1014 resident bac-
teria, comprising ~1,000 species, and they reside in the outer
sublayer of the mucosal barrier on the luminal side of the intestinal
epithelium (Figure 1). The vast majority (~90%) of the commen-
sal bacteria in humans and mice belong to two phyla: Firmicutes
and Cytophaga–Flavobacterium–Bacteroidetes. Though much of
the resident microbiota are of the same two phyla, there are differ-
ences in intestinal floral composition of individuals that arise at
the species level (16). Diversity of the intestinal microflora is sus-
ceptible to change due to environmental factors such as nutrition,
and there is variation (increases/decreases in quantity of certain
species of bacteria or increases/decreases in diversity of a particu-
lar genus of bacteria) in microbiota populations within different
age groups (17, 18).
The resident microbiota promote resistance to infection by
pathogenic microorganisms in several ways. First, they serve as
a microbial barrier by competing with pathogens for resources
at the outer mucosal sublayer, thereby limiting pathogenic bac-
terial colonization (8). Additionally, end products of metabolic
pathways of individual species of bacteria have been shown to
prevent pathogenic infection. For example, Bifidobacteria car-
bohydrate metabolism produces high concentrations of acetate,
which has been shown to prevent release of Shiga toxin during
infection with enterohemorrhagic (EHEC), thereby decreasing the
risk of toxin gaining access to the blood stream from where it
can otherwise cause lethal damage to target organs such as the
kidneys (19). Along the same lines, it is becoming more appre-
ciated that the composition of the intestinal microbiota may be
just as important in defending against infection as the quantity
of the commensal bacteria. For instance, selective reduction of
Lactobacilli and Enterococci/group D streptococci groups of bac-
teria through the use of low concentrations of antibiotics has
been shown to make mice more susceptible to colonization of
the epithelial surface with S. typhimurium without drastically
affecting the overall numbers of commensal bacteria (16). Fur-
ther investigation is needed to determine exactly which resident
microbiota are necessary to prevent other pathogens from col-
onizing the intestinal epithelium, especially since certain enteric
pathogens have developed mechanisms to subvert this microbial
form of protection.
Nevertheless, an emerging concept is that inflammation of
the mucosal epithelium plays a role in the bacterial fitness
of S. typhimurium. One of the more basic advantages of S.
typhimurium-induced inflammation is that the clinical manifes-
tation of diarrhea facilitates the spread of bacteria. Additionally,
it has been shown that unlike avirulent strains, wild-type S.
typhimurium is capable of out-competing commensal microbiota
in re-colonization experiments after treatment with antibiotics.
Furthermore, S. typhimurium exploits inflammation to promote
its own colonization. In this instance, S. typhimurium has been
shown to out-compete the resident microbiota in a mouse col-
itis model (20). One explanation for this phenomenon is that
inflammation provides S. typhimurium with a respiratory elec-
tron acceptor that members of the resident microbiota are unable
to utilize. In particular, reactive oxygen species generated by neu-
trophils (PMNs) during inflammation can react with endogenous
thiosulfate to form tetrathionate, a respiratory electron acceptor
(21). The ability to respire tetrathionate has been mapped to the
ttrRSBCA locus, which is located in SPI-2 (22). Under anaerobic
conditions in which thiosulphate was oxidized to tetrathionate,
S. typhimurium displays a growth advantage in comparison to
resident microbiota under the same conditions (21).
Both resident microbiota and S. typhimurium compete for
resources available for fermentation at the mucosal layer; how-
ever, resident microbiota are incapable of using the fermentation
end products (21). By reducing the tetrathionate made available by
the inflammatory response to infection, S. typhimurium is capable
of respiring the fermentation end products in anaerobic condi-
tions, thereby providing it with an advantage over the resident
microbiota (21). Remarkably, the growth benefit is conferred to S.
typhimurium only in the presence of inflammation, and it has been
suggested that a reason S. typhimurium has evolutionarily main-
tained its inflammation-inducing virulence mechanisms could be
to provide it with an ecological advantage at the mucosal surface
of the intestine (21).
PANETH CELLS
Paneth cells are specialized epithelial cells located at the base
of crypts of Lieberkuhn that generate and secrete antimicro-
bial peptides of ~20–40 amino acids in length (Figure 1). There
are four families of antimicrobial peptides: defensins, catheli-
cidins, histatins, and lactoferrin (Figure 1, Table 1). Defensins
are positively charged and directly interact with the negatively
charged membrane of pathogenic microorganisms resulting in
membrane destabilization and pore formation. Cathelicidins are
also positively charged, and they function in binding and neu-
tralizing lipopolysaccharides (LPS), ultimately resulting in pore
formation. Unlike defensins and cathelicidins, histatins do not
interact with the membranes of pathogenic bacteria. Instead,
histatins are ingested by the bacteria, inhibit mitochondrial respi-
ration, and kill the microorganism by generating reactive oxygen
species [for review, see Ref. (23)]. Lactoferrin is a cationic pro-
tein that sequesters iron, an essential nutrient for pathogenic
Table 1 | Summary of antimicrobial peptides.
Antimicrobial peptides Function Reference
Defensins (i.e., HD-5,
HD-6)
Destabilization of bacterial
membranes
(23, 25, 26)
Cathelicidins (i.e., CRAMP,
LL-37)
Neutralization of LPS (23, 27, 28)
Histatins Generation of reactive oxygen
species
(23)
Lactoferrins Sequestration of iron and
destabilization of bacterial
membranes
(23, 24)
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microorganisms. Additionally, lactoferrin can bind LPS and desta-
bilize bacterial membranes similar to defensins and cathelicidins
(23, 24). The antimicrobial activities of these peptides are non-
specific, as their activity provides a first line of defense against both
Gram-positive and Gram-negative bacteria, fungi, and enveloped
viruses.
All antimicrobial peptides are produced in an inactive, pre-
propeptide form and must be processed (i.e., enzymatically) either
intracellularly or extracellularly to become active (10). For exam-
ple, the alpha-defensin HD-5 is stored in Paneth cells in an inactive,
pre-propeptide form and is processed by trypsin into its active
form (29). Antimicrobial peptide production has been shown to
be upregulated in response to bacteria (30). However, pathogenic
microorganisms have developed methods to counteract the effec-
tiveness of the antimicrobial peptides. Examples of these meth-
ods include covalently modifying the bacterial cell membrane to
reduce its net negative charge, using bacterial proteases to catalyt-
ically inactivate the antimicrobial peptides, and using ATP-driven
pumps to physically remove the antimicrobial peptides from the
bacterial cytoplasm [for review, see Ref. (31)]. Certain pathogens
have developed resistance to the antimicrobial activities of the pep-
tides secreted by Paneth cells in order to promote their intracellular
survival.
Antimicrobial peptides that provide protection against S.
typhimurium infection have been identified using transgenic
mouse models. Alpha-defensin HD-5 transgenic mice were shown
to consistently have a significant reduction in the S. typhimurium
burden in the distal intestine and spleen in comparison to wild-
type mice that do not express this antimicrobial peptide, indicating
the antimicrobial activity of HD-5 conferred the transgenic mice
with an enhanced ability to kill S. typhimurium in the intestinal
lumen (26). Another alpha-defensin shown to provide increased
defense against S. typhimurium infection is HD-6, which binds
bacterial membrane proteins, thereby inhibiting contact of S.
typhimurium with epithelial cells (25). Since HD-6 does not kill S.
typhimurium, HD-6 transgenic mice do not display the decrease in
bacterial burden seen with HD-5 transgenic mice; however, HD-
6 transgenic mice display a profound increase in survival rate in
comparison to wild-type mice that do not express this antimicro-
bial peptide, indicating the antimicrobial activity of HD-6 must
act in concert with another defense mechanisms at the mucosal
barrier to eliminate S. typhimurium (25).
In addition to defensins, mouse models have also identi-
fied the significance of cathelicidins and lactoferrin. The sole
murine cathelicidin called cathelin-related antimicrobial peptide
(CRAMP) has been shown to impair intracellular replication
of S. typhimurium in vivo and in vitro (27). Additionally, S.
typhimurium displayed enhanced survival in macrophages derived
from CRAMP-deficient mice (27). CRAMP is similar in structure
and antimicrobial properties to the only human cathelicidin called
LL-37, which has been shown to display a broad spectrum of activ-
ity against bacteria including S. typhimurium (28). A recent study
identified the in vivo effect of lactoferrin on S. typhimurium. In this
study, mice treated with bovine lactoferrin displayed a reduction
in severity, mortality, and inflammation during infection, indicat-
ing the antimicrobial properties of lactoferrin are significant for
defense against S. typhimurium (24).
THE EPITHELIAL BARRIER
In addition to mucosal defenses described above, interactions
between cells of the epithelial cells in the monolayer also pro-
vide a barrier against bacterial entry. Tight junctions are dynamic
structures composed of zonula occludens (ZO) and junctional
adhesion molecules that effectively adhere the cells of the epithe-
lial monolayer to each other (Figure 1) (8). The integrity of this
seal is maintained by the interaction of tight junction compo-
nents with the actin cytoskeleton. However, the permeability of
this seal is regulated by physiological conditions, and it therefore
can be manipulated. For example, treating epithelial monolayers
with inflammatory cytokines, such as IL-1β, increases the perme-
ability of the tight junctions (32). The increase in tight junction
permeability can facilitate the translocation of bacteria from the
lumen to the subepithelial region, making them a target for patho-
genic manipulation. Pathogenic microorganisms can accomplish
the manipulation of tight junctions by usurping signaling path-
ways, such as the Rho-GTPase pathway, which regulates actin
cytoskeleton rearrangement (8).
Salmonella typhimurium infection has been shown to regu-
late certain tight junction proteins, which ultimately promotes
translocation of the bacteria through the epithelial cell mono-
layer (33). Upon infection with S. typhimurium, occludin becomes
dephosphorylated and subsequently removed from epithelial tight
junctions (33). Additionally, ZO-2 is recruited from the cytosol to
membrane, indicating S. typhimurium alters the intracellular dis-
tribution of this tight junction protein (33). Surprisingly, ZO-1,
which is normally regulated by pathogens in a similar manner to
ZO-2, appears to be degraded during S. typhimurium infection
(33). Manipulation of tight junction proteins serves to disrupt the
epithelial barrier by increasing its permeability, thereby allowing
S. typhimurium to more effectively invade the basolateral side of
the epithelial cell monolayer.
In order to mount a successful infection, S. typhimurium must
disrupt some aspects of the protective mechanisms employed by
the mucosal epithelium. As mentioned previously, the two T3SS
and the secreted bacterial effector proteins promote entry, inflam-
mation, and intracellular survival. In addition, in order to subvert
the action of antimicrobial peptides, S. typhimurium uses the two-
component system PhoQ/PhoP, which regulates the expression
of SPI-2 encoded genes as well. Specifically, PhoP/PhoQ regula-
tors promote remodeling of the bacterial envelope, resulting in
increased resistance to antimicrobial peptides that recognize LPS.
Furthermore, the PhoP/PhoQ regulators repress transcription of
genes for the T3SS, in attempt to avoid detection, and induce pro-
tective mechanisms against hydrogen peroxide (10). In addition
to rearranging the actin cytoskeleton and targeting specific tight
junction proteins, S. typhimurium also manipulates tight junctions
via the action of SipA, SopE, SopE2, and SopB (8). These effec-
tor proteins induce Rho-GTPase activation, and inhibition of this
effector-induced Rho-GTPase activation prevents tight junction
disruption (8).
The manipulation of tight junctions has also recently been
shown to facilitate the transmigration of PMNs across the
epithelial cell monolayer (33). The primary mechanism of PMN
migration in S. typhimurium infection involves the recruitment
of neutrophils into the subepithelium and the formation of a
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chemoattractant gradient that directs the neutrophils into the
lumen (Figure 2, discussed in detail later). However, recent
research implicates the disruption of tight junctions in facilitating
PMN migration even in the absence of the chemoattractant gradi-
ent (33). Thus, S. typhimurium not only modulates the release of
neutrophil chemoattractants that induce PMN migration, but also
directly influences the tight junctions that maintain the fidelity
of the epithelial cell monolayer in order to promote bacterial
translocation and PMN transepithelial migration.
LAMINA PROPRIA
The lamina propria is the connective tissue underlying the epithe-
lial cell monolayer. It contains multiple immune effector cells
including B cells, T-cells, dendritic cells, natural killer (NK) cells,
macrophages, eosinophils, and mast cells. If enteric pathogens are
capable of surmounting the barriers described above and penetrate
the intestinal epithelium, a coordinated immune response utiliz-
ing these immune effector cells is activated. Sampling of luminal
antigens occurs in specialized cells called M cells, which transport
the antigens to a subepithelial region where the antigen comes
in contact with dendritic cells. Dendritic cells bound to antigen
then migrate to the mesenteric lymph node to present the lumi-
nal antigens to naïve T-cells and B cells. These naïve lymphocytes
then differentiate into several effector cells including CD8 cyto-
toxic T-cells, CD4 helper T-cells, regulatory T-cells, and antibody
secreting B cells. Although this marks the beginning of a coordi-
nated immune response to pathogenic bacteria, the resting lamina
propria does have protective functions that provide an added layer
of defense prior to the full activation of the mucosal immune
system.
The most abundant B cell found in the lamina propria is the
IgA-secreting B cell (Figure 1). Secreted IgA is also the primary
secreted immunoglobulin found in the thick mucus layer. One of
the main roles of secreted IgA is a process called immune exclu-
sion, which includes prevention of pathogens from adhering to the
mucosal surface on the luminal side of the intestinal epithelium
and removal of antigens from the basolateral side of the intestinal
epithelium. On the luminal side, secreted IgA primarily interferes
FIGURE 2 | Mechanism of PMN recruitment and PMN transmigration.
S. typhimurium utilizes its T3SS to secrete effector proteins into epithelial
cells to activate inflammatory signaling pathways. In particular, the activation
of Rho-GTPases by SopE, SopE2, and SopB result in the induction of
mitogen-activated protein kinase (MAPK) pathways. The stimulated
pathways include ERK, JNK, and p38, resulting in the terminal activation of
major inflammatory regulator NF-κB. Activation of NF-κB results in the
basolateral secretion of IL-8 producing a chemoattractant gradient that
recruits neutrophils to the subepithelial region from the underlying
microvasculature. Th17 cells are also present in the subepithelial region, and
function to recruit and activate neutrophils in the subepithelium. PMN
transmigration is facilitated by another chemattractant HXA3. HXA3 is a
bioactive eicosanoid that is synthesized from arachidonic acid via the
12/15-lipoxygenase pathway in epithelial cells. It is secreted into the lumen
via the action of an ATP-binding cassette transporter called MRP2. S.
typhimurium effector protein SipA stimulates the recruitment of PKC-α to
the apical membrane, which in addition to the ERM protein ezrin, modulate
the localization of MRP2 to the apical membrane, thereby allowing secretion
of HXA3 into the lumen and production of the chemoattractant gradient that
induces PMN transmigration.
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with microbial adhesins, whereas on the basolateral side secreted
IgA functions in an export mechanism by binding antigens and
shuttling them back across the epithelial monolayer into the lumen
(34). Secreted IgA does not activate an inflammatory immune
response when it neutralizes pathogenic microorganisms, thereby
upholding the integrity while preventing inflammation-induced
damage of the mucosal epithelium (35).
Secreted IgA also has a direct effect on the virulence mech-
anisms of certain pathogens. In S. typhimurium infection, it has
been shown that a monoclonal, polymeric IgA antibody Sal4 binds
the O-antigen (O-Ag) component of LPS on the bacterial mem-
brane, resulting in its destabilization [Ref. (36); for review, see
Ref. (37)]. Recent evidence indicates that the bacterial membrane
destabilization results in impaired T3SS translocon formation,
decrease in effector protein delivery, and decrease in flagellum-
based motility (36). S. typhimurium responds to the binding of
Sal4 to O-Ag by triggering exopolysaccharide (EPS) production
and biofilm formation, though this response renders the bac-
teria non-invasive and avirulent (38). The mechanism of EPS
production and biofilm formation has been attributed to the acti-
vation of a cyclic dimeric guanosine monophosphate-dependent
pathway via an inner membrane diguanylate cyclase YeaJ (38). Fur-
thermore, it has been suggested that the triggering of this pathway
by S. typhimurium could be a mechanism to restore membrane
stability, as EPS production could serve to shed IgA antibody or
increase resistance to other luminal insults (38).
The resting lamina propria contains a heterogeneous popula-
tion of CD8 cytotoxic T-cells, CD4 helper T-cells, and regulator
T-cells even in the absence of pathogenic infection. The number
of effector T-cells in the resting lamina propria would in any other
tissue indicate an inflammatory response; however, the amount of
T-cells present in the mucosal tissue of the gut is more indicative
of constant immune surveillance and recognition than chronic
inflammation. The cytokines produced by these T-cells maintain
the mutualistic response to resident microbiota, stimulate pro-
duction of IgA, induce secretion of antimicrobial peptides, and
promote epithelial repair. Additionally, in the absence of pro-
inflammatory cytokines (which are usually produced by innate
immune cells in the presence of pathogen), the dendritic cells in
the resting lamina propria contribute to maintaining tolerance to
non-pathogenic antigens by promoting the production of CD4
regulatory T-cells. Regulatory T-cells produce immunosuppres-
sive cytokines that inhibit T-cell proliferation and dendritic cell
differentiation, which prevents unnecessary immune response to
innocuous antigens (35).
In addition to a heterogeneous population of T-cells, the
macrophages in the resting lamina propria play a key role in
host defense against S. typhimurium infection, as well. The
macrophages of the resting lamina propria can be divided
into two different classes: M1 (“classically activated”), and M2
(“alternatively activated”) polarized macrophages. M1 polarized
macrophages are pro-inflammatory and display high phagocytic
and antimicrobial activity, whereas M2 polarized macrophages are
anti-inflammatory and display low phagocytic and antimicrobial
activity. Hence, with this type of opposing macrophage regulation
it is considered that M1 macrophages function in the clearance
of infection versus M2 macrophages that assist in wound healing
and suppression of T-cell function. Manipulation of macrophage
polarization by S. typhimurium has become increasingly realized
as a defense mechanism against bacterial clearance [for review, see
Ref. (39, 40)]. A recent study demonstrated that the SPI-1 T3SS
enables S. typhimurium to guide macrophage toward the M2 polar-
ization (40). This type of control permits S. typhimurium to escape
the more hostile environment of M1 polarized macrophages,
resulting in a macrophage-specific decrease in pro-inflammatory
signaling (40).
The mechanism of immunity to invasive Salmonella is still dis-
puted, specifically the relevance of cell-mediated versus humoral
immunity. The debate is complicated by attempts to compare dif-
ferent experimental models, which vary in route of Salmonella
administration and/or susceptibility of mouse strains to Salmo-
nella. In terms of cellular immunity, mice deficient for TCR α/β,
MHC class II, or interferon-γ (IFN-γ) receptor fail to clear a pri-
mary Salmonella infection that can be resolved in normal mice
(41, 42). Recently, it has also been shown that Thy1+ NK cells
are essential for the early production of IFN-γ during control
of Salmonella infection (43). CD8+ T-cells seem to also play a
role in Salmonella clearance (44). It has also been documented
that Salmonella infection promotes the expansion of intestinal
intraepithelial lymphocytes (iIELs) and the activation of particu-
larly, CD8+ TCRγδ+ iIELs, which in turn trigger cytolytic activity
against Salmonella-infected epithelial cells (44).
The role of antibody-producing immune cells or B cells against
Salmonella is still controversial (45–47). Some reports have shown
the importance of antibody production and T-cell activation for
protection from virulent Salmonella (45, 46). However, another
study reported that the protective immunity provided by an atten-
uated S. typhimurium strain required B cells independently of
antibody production, proposing that they confer protective immu-
nity by presenting antigen to T-cells and acting as a source of
inflammatory cytokines (47). It has also been demonstrated that
transfer of immune serum into B cell-deficient mice can partially
but not completely provide protective immunity (48).
THE TYPE III SECRETION SYSTEM: CO-OPTING HOST
PATHWAYS TO PROMOTE ENTRY AND IMMUNE EVASION
Upon contact of S. typhimurium with the epithelial cell mono-
layer, the SPI-1 effector proteins SopE, SopE2, and SopB initi-
ate the process of bacterial entry by activating host cell Rho-
GTPases resulting in actin rearrangements (49, 50). SipA is
another SPI-1 effector protein that antagonizes actin depoly-
merizing agents and tethers actin monomers together to form
membrane ruffles, which promotes bacterial internalization
(51). S. typhimurium is engulfed by epithelial cells through a
macropinocytosis event termed bacterial-mediated endocytosis,
and is ultimately contained within in a membrane-bound vesicle
called a macropinosome [more commonly termed the Salmonella
containing vacuole (SCV)]. Although prior studies thought that
SopB was the sole mediator of macropinosome formation, a coop-
erative interaction regulated by the phosphatase activity of SopB
has implicated SopD as another mediator of this process (49).
Salmonella typhimurium also targets antigen-sampling micro-
fold (M) cells to translocate across the gut epithelium. M cells
constitute a small subset of highly specialized follicle-associated
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epithelium (FAE) enterocytes overlying lymphoid follicles in
the gut, and are characterized by an irregular brush border, a
reduced glycocalyx and lysosomal apparatus, and are programed
to efficiently transcytose a wide variety of macromolecules and
microorganisms from the gut lumen to the underlying immune
inductive Peyer’s patches (PPs) (52). Recent evidence shows the
S. typhimurium type III effector protein SopB also induces an
epithelial–mesenchymal transition of the FAE into M cells. This
cellular transdifferentiation is a result of SopB-dependent acti-
vation of Wnt/β-catenin signaling leading to induction of both
receptor activator of NF-κB ligand (RANKL) and its receptor
RANK. The autocrine activation of RelB-expressing FAE entero-
cytes by RANKL/RANK induces the EMT-regulating transcription
factor Slug that marks epithelial transdifferentiation into M cells.
Thus, S. typhimurium may also transform primed epithelial cells
into M cells to promote host colonization and invasion (52, 53).
Following bacterial entry of mucosal epithelia, S. typhimurium
employs a second set of SPI-1 effector proteins to ensure repair
of the actin cytoskeleton. SptP is one such effector that is directly
responsible for reversing the affects of SopE and SopE2. SptP pro-
motes restoration of the epithelial cell membrane by functioning
as a GTPase-activating protein for the Rho-GTPase proteins Rac-1
and Cdc42 (54). Similarly, as several of the early SPI-1 effectors
induce inflammation of the mucosal epithelium, there are effec-
tor proteins that have an anti-inflammatory function, providing
S. typhimurium with a form of regulatory control over the inflam-
matory state of the mucosal tissue (inflammation induced by S.
typhimurium will be discussed later).
After successful entry into epithelial cells and restoration of the
epithelial cell membrane, S. typhimurium relies primarily on the
T3SS encoded by SPI-2 to survive and replicate intracellularly by
translocating SPI-2 effector proteins across the membrane of the
SCV into the epithelial cell cytoplasm. SPI-2 effector proteins that
appear to be necessary for survival and virulence of S. typhimurium
inside the SCV are SifA, SseJ, SseF, SseG, SopD2, and PipB2 (50,
55, 56). SifA has been shown to promote tubulation of the SCV
through correlation with another effector protein SseJ (57). SCV
tubulation in conjunction with the effects of SseF and SseG localize
the SCV to the perinuclear region in close proximity of the Golgi
apparatus (58). The localization of the SCV is important for intra-
cellular survival because vesicular trafficking through the Golgi
network allows for the acquisition of nutrients, thereby allowing
the establishment of a replication niche for Salmonella (58, 59).
An additional means by which SPI-2 promotes intracellular
survival of S. typhimurium is by encoding factors that mediate the
evasion of immune responses. SPI-2 promotes protection from
reactive oxygen intermediates produced by macrophages, specifi-
cally nitric oxide (NO) and NADPH oxidase [for review, see Ref.
(60–62)]. S. typhimurium has been shown to evade NO-mediated
killing in macrophages by inhibiting IFN-γ-induced NO produc-
tion in a SPI-2-dependent manner (61). SPI-2 is also involved in
avoiding NADPH oxidase-dependent killing by interfering with
the trafficking of NADPH oxidase (62). Although the specific SPI-
2 effector proteins involved in the evasion of both NO-dependent
and NADPH oxidase-dependent killing of S. typhimurium have
yet to be identified, the established role of SPI-2 in evasion of
both immune responses suggests a possible role for one or more
encoded effector proteins in promoting resistance to reactive
oxygen intermediates in macrophages.
SALMONELLA-INDUCED INFLAMMATION
IMMUNE RECOGNITION
Pathogen-associated molecular patterns (PAMPs) are recognized
by pattern-recognition receptors (PRRs), namely toll-like recep-
tors (TLRs), located on inflammatory cells and epithelial cells.
TLRs can recognize a wide range of PAMPs, though some TLRs do
show some specificity for particular PAMPs. For example, TLR4 is
mostly involved in recognition of LPS and TLR5 is mostly involved
in the recognition of bacterial flagellin. TLRs in epithelial cells are
localized to the basolateral or apical membrane, as well as in intra-
cellular vesicles. Thus, TLRs can recognize pathogens on either
side of the epithelial cell monolayer and endocytosed extracellular
pathogens. Additionally, inflammatory cells, such as macrophages,
expressing TLRs can also recognize PAMPs. The importance of
some TLRs, specifically TLR4 and TLR5, in S. typhimurium infec-
tion have been established, as mutating them has been shown to
increase susceptibility to infection and inflammation (35). Intra-
cellular recognition of bacteria or their products in the cytoplasm
is also mediated by nucleotide-binding oligomerization domain
proteins NOD1 and NOD2. NOD1 recognizes peptides contain-
ing diaminopimelic acid, which is a component of Gram-negative
bacterial cell walls, whereas NOD2 recognizes a muramyl dipep-
tide present in the peptidoclycan layers of both Gram-positive
and Gram-negative bacteria. Similar to TLRs, mutations in NOD1
and NOD2 proteins increase susceptibility to disease and infection
caused by intracellular bacteria [for review, see Ref. (63, 64)].
RECRUITMENT OF IMMUNE CELLS
The host immune system also activates inflammatory pathways in
response to infection with S. typhimurium. The binding of TLRs
and NOD1/NOD2 proteins to their respective ligands activates
the NF-kB pathway leading to production of pro-inflammatory
cytokines and chemokines. Basolateral secretion of the cytokine
IL-8 recruits neutrophils and is necessary for PMN migration into
the subepithelium. Additional chemokines, such as CCL20, play a
role in attracting immature dendritic cells, which upon exposure
to antigen, can mature and present antigenic peptides to naïve B
and T-cells in the mesenteric lymph nodes (35). S. typhimurium
can also react with TLRs on macrophages in the subepithelial
region after being transcytosed through M cells, thereby activating
and inducing them to also produce cytokines and chemokines.
Cytokines produced by these activated macrophages include IL-
1, IL-6, and IL-23, all of which drive the differentiation of TH17
cells whose primary function in the subepithelium is recruiting
and activating neutrophils (Figure 2) (35, 65). Other cytokines
produced by these activated macrophages include IL-18 and IL-
12, both of which drive the IFN-gamma-dependent production of
antigen-specific TH1 cells (35).
MECHANISM OF NEUTROPHIL RECRUITMENT
A hallmark of S. typhimurium-induced inflammation is the
recruitment of PMNs from the underlying microvasculature to
the subepithelial region of the epithelial cell monolayer (Figure 2).
The neutrophils then migrate across the monolayer into the lumen,
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resulting in the inflammatory pathology of Salmonellosis. New
information is shedding light on the molecular mechanisms and
signaling pathways involved in neutrophil recruitment across the
intestinal epithelium. As discussed above, it is becoming increas-
ingly appreciated how inflammation induced by S. typhimurium
increases its pathogenic bacterial fitness.
In addition to promoting bacterial entry, many effector proteins
encoded by SPI-1 also activate inflammatory signaling pathways.
The activation of Rho-GTPases by SopE, SopE2, and SopB result in
the induction of mitogen-activated protein kinase (MAPK) path-
ways (Figure 2). In particular, the ERK, JNK, and p38 pathways
are stimulated, resulting in the terminal activation of inflamma-
tory regulators AP-1 and NF-κB (Figure 2) [Ref. (66); for review,
see Ref. (50)]. Furthermore, the activation of NF-κB and AP-1
stimulates the secretion of the cytokine IL-8 on the serosal side of
the epithelial cell monolayer, a requirement for the recruitment of
neutrophils to the subepithelial region (Figure 2) (67). Although
IL-8 is necessary for PMN migration into the lumen, it has been
shown that IL-8 alone is not sufficient enough to drive the migra-
tion across the epithelial cell monolayer [Ref. (67, 68); for review,
see Ref. (69)].
The migration of neutrophils from the basolateral side to the
luminal side of the epithelial cell monolayer is driven by another
PMN chemoattractant, hepoxilin A3 (HXA3) (Figure 2) (68, 70).
HXA3 is a bioactive eicosanoid that is synthesized from arachi-
donic acid via the 12/15-lipoxygenase pathway in epithelial cells
(Figure 2) (70). After synthesis, HXA3 is secreted from the apical
surface of epithelial cells by an ATP-binding cassette transporter
called multidrug resistant protein 2 (MRP2) (Figure 2) (71). Secre-
tion of HXA3 into the lumen forms a chemoattractant gradient
that causes neutrophils to migrate from the region underlying the
epithelial cell monolayer into the lumen (Figure 2) (70).
Activation of the effector protein SipA has been shown to be
necessary for induction of HXA3 synthesis and the resulting PMN
migration (Figure 2) (72). Remarkably, the mechanism for acti-
vating SipA was recently shown to require processing by the host
enzyme caspase-3 at a particular cleavage site, resulting in two dis-
tinct effector domains (73). Furthermore, the two domains were
shown to be functionally different. The ability to promote PMN
migration is confined to the SipA N-terminal domain, whereas
the C-terminal domain has been shown to be involved in actin
rearrangement (72, 73). The current understanding of the mech-
anism of SipA-dependent synthesis of HXA3 is that SipA induces
the recruitment of ADP-ribosylation factor 6 (ARF6) to the apical
membrane of the epithelial cells. ARF6 activates phospholipase D,
which generates phosphatidic acid. Phosphatidic acid is then con-
verted to diacylglycerol (DAG), which recruits protein kinase C-α
(PKC-α) to the apical membrane (Figure 2). PKC-α, in addition to
an ERM protein ezrin, modulate the localization of MRP2 to the
apical membrane of epithelial cells, thereby allowing the secretion
of HXA3 into the lumen and production of the chemattractant
gradient that induces neutrophil transmigration (Figure 2) (72,
74, 75).
CONCLUSION
The architecture of the mucosal immune system, including
mucins, antimicrobial peptides, resident microbiota, paracellular
junctions, and effector cells of the lamina propia, functions to pre-
vent pathogenic bacteria from disrupting the epithelial cell mono-
layer and causing disease. If enteric pathogens are able to penetrate
these barriers, then it results in a host inflammatory response and
eventually activation of an adaptive immune response, designed
to eradicate the intruding pathogen. However, S. typhimurium has
evolved systems, namely the SPI-1 and SPI-2 T3SS, to manipu-
late the defensive mechanisms of the mucosal immune system
in order to develop a replication niche in the mucosal epithelium.
Additionally, the ability of S. typhimurium to exploit inflammation
allows it to penetrate the epithelial barriers, a condition in which
activation of the adaptive immune response would be required for
pathogenic clearance. Investigating how S. typhimurium exploits
host cell signaling pathways will allow for increased understanding
in its pathogenesis, and consequently provide further insight into
how inflammation can seemingly result in both increased bacterial
fitness and increased pathogenic clearance.
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